Clinical Trial Update: A Dose-escalating Clinical Trial With KH176 [Phase 1]

View source ↗

Summary

Phase 1 dose-escalation trial of KH176 in mitochondrial diseases completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leigh Syndrome
• Melas
• Mitochondrial Disease

Drugs mentioned

• KH176 (KH176)

Snippet

Sponsor: Khondrion BV | Conditions: MELAS, LHON | Phase 1 | Status: COMPLETED | Results posted: 2020-11-12